Wellington Biomedical Innovation Master Investors Cayman I

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Wellington Biomedical Innovation Master Investors Cayman I
CIK #0001903360, 0001787092
EDGAR Form CIK 2011 - 2026
3 [0001787092]
4 [0001787092]
D [0001787092]
SC 13G [0001787092]
3 [0001903360]
4 [0001903360]
SC 13G [0001903360]
Form 13D/13G Filer Form 13D/13G Subject Filed
Wellington Biomedical Innovation Master Investors Cayman II LP Promis Neurosciences Inc [2026-03-18]
Wellington Biomedical Innovation Master Investors Cayman II LP MBX Biosciences Inc [2024-09-20]
Wellington Biomedical Innovation Master Investors Cayman I LP Verve Therapeutics Inc [2021-06-28]
Wellington Biomedical Innovation Master Investors Cayman I LP Aligos Therapeutics Inc [2020-10-22]
Form 3/4/5 Subject 2011 - 2026
Avalyn Pharma Inc
Wellington Biomedical Innovation Master Investors Cayman I
Metsera Inc
Upstream Bio Inc
Wellington Biomedical Innovation Master Investors Cayman I
Zenas BioPharma Inc
MBX Biosciences Inc
Artiva Biotherapeutics Inc
Boundless Bio Inc
CARGO Therapeutics Inc
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Metsera Inc MTSR
Series B Preferred Stock · derivative
2025-01-30 Conversion 4,365,079 $0.00
Metsera Inc MTSR
Common Stock
2025-01-30 Conversion 1,857,699
Upstream Bio Inc UPB
Series B redeemable convertible preferred stock · derivative
2024-10-15 Conversion 852,940 $0.00
Upstream Bio Inc UPB
Common Stock
2024-10-15 Conversion 894,733
MBX Biosciences Inc MBX
Common Stock
2024-09-16 Conversion 1,386,335
MBX Biosciences Inc MBX
Common Stock
2024-09-16 Conversion 403,787
MBX Biosciences Inc MBX
Series C Preferred Stock · derivative
2024-09-16 Conversion 4,854,368 $0.00
Zenas BioPharma Inc ZBIO
Common Stock
2024-09-16 Conversion 420,271
Zenas BioPharma Inc ZBIO
Common Stock
2024-09-16 Conversion 180,635
Zenas BioPharma Inc ZBIO
Common Stock
2024-09-16 Conversion 200,718
Zenas BioPharma Inc ZBIO
Series A Convertible Preferred Stock · derivative
2024-09-16 Conversion 1,568,480
Zenas BioPharma Inc ZBIO
Series C Convertible Preferred Stock · derivative
2024-09-16 Conversion 1,742,858
Zenas BioPharma Inc ZBIO
Series B Convertible Preferred Stock · derivative
2024-09-16 Conversion 3,649,263
MBX Biosciences Inc MBX
Series B Preferred Stock · derivative
2024-09-16 Conversion 16,666,666 $0.00
Artiva Biotherapeutics Inc ARTV
Common Stock
2024-07-22 Other 49,019 $10.20 499,994
Artiva Biotherapeutics Inc ARTV
Common Stock
2024-07-22 Conversion 145,089
Artiva Biotherapeutics Inc ARTV
Series B Preferred Stock · derivative
2024-07-22 Conversion 145,089
Boundless Bio Inc BOLD
Common Stock
2024-04-02 Conversion 366,300
Boundless Bio Inc BOLD
Common Stock
2024-04-02 Conversion 189,933
Boundless Bio Inc BOLD
Series C Preferred Stock · derivative
2024-04-02 Conversion 7,142,857 $0.00
showing 20 of 59 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com